Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Scher, H. I.; Graf, R. P.; Schreiber, N. A.; Winquist, E.; McLaughlin, B.; Lu, D.; Orr, S.; Fleisher, M.; Lowes, L.; Anderson, A. K. L.; Wang, Y.; Dittamore, R. V.; Allan, A. L.; Attard, G.; Heller, G.
Abstract Title:	Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title:	2018 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	6 Suppl.
Meeting Dates:	2018 Feb 8-10
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-02-20
Language:	English
ACCESSION:	WOS:000436179500268
DOI:	10.1200/JCO.2018.36.6_suppl.273
PROVIDER:	wos
Notes:	Meeting Abstract: 273 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/137337